Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Jun 25, 2021
Document Date
Jun 23, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
Crowley John F